ARCHIVES

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

EARLY Breast Cancer Screening Bill Gains Traction Among Jewish Groups

June 19, 2009

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

In Brief: RFP Offers Patent Rights Instead Of Profit; ACS, NCI Plan More Joint Projects; BC Report Sept. 30

September 20, 1974

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

June 21, 2002

Program Announcement; NCI Seeks Studies Of Breast Cancer In Northeast U.S.

January 22, 1993

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004